Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Honorary achievements of Wuhan United Pharmaceutical Co., Ltd.
Honorary achievements of Wuhan United Pharmaceutical Co., Ltd.
20 1 1 On September 23rd, the fifth new Chinese medicine "Valeriana extract capsule" passed the scientific and technological achievements appraisal of Wuhan Science and Technology Bureau. Through novelty retrieval, this project developed a new Chinese medicine for gastrointestinal spasmolysis with Valeriana officinalis as raw material for the first time at home and abroad. Valeriana extract capsule, formerly known as Jingtongding Capsule, won the Innovation Fund of the Ministry of Science and Technology in June 2008.

20 12 year 10 month, 1 1, the project of "innovating Valeriana extract capsule industrialization" was included in the technological innovation fund for small and medium-sized enterprises in Wuhan in 20 12 year and was announced.

20 13 was recommended by Wuhan Science and Technology Bureau to declare "Innovation Award for SMEs in Hubei Province" in April.

On July 5, 20 13, according to the Notice of Wuhan East Lake New Technology Development Zone Management Committee on Carrying out Gazelle Enterprise Certification in 20 13, it was included in the list of gazelle enterprises to be certified in East Lake New Technology Development Zone in 20 13 and publicized.

20 13 was listed as "Innovation Award for Small and Medium-sized Sci-tech Enterprises" by Hubei Science and Technology Department in September and publicized.

20 14 On February 25th, 20 13 Hubei Science and Technology Awards Conference was held in Wuhan. Won the "SME Innovation Award" in the 20 13 Hubei Science and Technology Awards Conference. (CertificateNo.: 2013c-031-kloc-0/-021-0/2)

February 20 14 The project "Trial and Clinical Study of Valsartan Xintai Tablets" was included in the key technical research project of 20 14 by Wuhan Science and Technology Bureau.

On June 7th, 20 14, according to the Notice of Wuhan East Lake New Technology Development Zone Management Committee on Carrying out the Identification of Gazelle Enterprises in 20 14, it was included in the list of gazelle enterprises to be identified in East Lake New Technology Development Zone in 20 14 and publicized.

In July of 20 14, it was rated as "National Advanced Enterprise in Quality Management of Pharmaceutical Industry in 20 14" (China Pharmaceutical Association Certificate No.20 14Z5 1), which was approved by experts organized by the Selection Office of China Pharmaceutical Industry Association.

In August of 20 14, according to the Notice of Wuhan East Lake New Technology Development Zone Management Committee on Carrying out the Identification of Gazelle Enterprises in 20 14, it was finally recognized as "Gazelle Enterprise" in 20 14 through the procedures of enterprise declaration, department consultation and online publicity.

In August of 20 15, according to the Notice of Wuhan East Lake New Technology Development Zone Management Committee on Carrying out the Identification of Gazelle Enterprises in 20 15, it was finally identified as "Gazelle Enterprise" in 20 15 through the procedures of enterprise declaration, department consultation and online publicity.